Skip to main content

Closed

FLNA: Filana Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-72.1%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio2.19×

Filana Therapeutics, Inc.

FLNANASDAQ Global Market·USD·Closed

Filana Therapeutics, Inc.

FLNANASDAQ·USD·Closed

$1.01

+5.21%

$1.01

+$0.05 (5.21%)

52W Range

4thpctl

Volume

0.88×avg

Mkt Cap

48.79MUSD

P/E

-1.2TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.88×avg

Market Cap

48.79MUSD

P/E Ratio

-1.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings